A glimpse at LifeStance Health Group Inc.’s potential climb to old highs

In the latest session, LifeStance Health Group Inc. (NASDAQ: LFST) closed at $4.95 down -0.60% from its previous closing price of $4.98. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 511302 shares were traded.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

For a deeper understanding of LifeStance Health Group Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.14.

Upgrades & Downgrades

On March 17, 2022, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $19 to $10.

JP Morgan Downgraded its Overweight to Neutral on November 09, 2021, whereas the target price for the stock was revised from $24 to $12.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 when Gouk Warren sold 15,106 shares for $7.20 per share. The transaction valued at 108,763 led to the insider holds 5,967,991 shares of the business.

Gouk Warren sold 15,106 shares of LFST for $113,144 on Oct 31. The Chief Administrative Officer now owns 5,983,097 shares after completing the transaction at $7.49 per share. On Oct 24, another insider, Gouk Warren, who serves as the Chief Administrative Officer of the company, sold 15,106 shares for $7.06 each. As a result, the insider received 106,648 and left with 5,998,203 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.32 while its Price-to-Book (P/B) ratio in mrq is 1.16.

Stock Price History:

Over the past 52 weeks, LFST has reached a high of $11.25, while it has fallen to a 52-week low of $4.77. The 50-Day Moving Average of the stock is 7.3438, while the 200-Day Moving Average is calculated to be 7.6127.

Shares Statistics:

For the past three months, LFST has traded an average of 737.30K shares per day and 975.29k over the past ten days. A total of 357.52M shares are outstanding, with a floating share count of 317.91M. Insiders hold about 12.70% of the company’s shares, while institutions hold 82.50% stake in the company. Shares short for LFST as of Oct 13, 2022 were 9.98M with a Short Ratio of 9.81M, compared to 9.28M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.65% and a Short% of Float of 13.58%.

Earnings Estimates

There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.18, while EPS last year was -$0.35. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.08 and low estimates of -$0.18.

Analysts are recommending an EPS of between -$0.55 and -$0.74 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.19, with 5 analysts recommending between -$0.1 and -$0.33.

Revenue Estimates

A total of 6 analysts believe the company’s revenue will be $219.65M this quarter.It ranges from a high estimate of $223.48M to a low estimate of $218.2M. As of the current estimate, LifeStance Health Group Inc.’s year-ago sales were $171.36M, an estimated increase of 28.20% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $236.16M, an increase of 24.30% less than the figure of $28.20% in the same quarter last year. There is a high estimate of $238.67M for the next quarter, whereas the lowest estimate is $233M.

A total of 7 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $874.14M, while the lowest revenue estimate was $865M, resulting in an average revenue estimate of $868.13M. In the same quarter a year ago, actual revenue was $667.51M, up 30.10% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.08B in the next fiscal year. The high estimate is $1.14B and the low estimate is $1.05B. The average revenue growth estimate for next year is up 24.90% from the average revenue estimate for this year.